We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine... Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market. Show more
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw PR Newswire BURLINGTON, N.C., April 15, 2024 Innovative GFAP...
Labcorp Declares Quarterly Dividend PR Newswire BURLINGTON, N.C., April 11, 2024 BURLINGTON, N.C., April 11, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and...
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit PR Newswire BURLINGTON, N.C., April 10, 2024 The first at-home mpox testing kit provides patients with...
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs PR Newswire BURLINGTON, N.C., April...
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research PR Newswire BURLINGTON, N.C., April 5, 2024 Labcorp Plasma Detect is the...
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research PR Newswire BURLINGTON, N.C., April 2, 2024 Researchers...
Longstanding partnership deepens with new financing, beta access to clinical manufacturing instruments, and AACR data presentations Xcell Biosciences Inc. (Xcellbio), an instrumentation company...
The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab PR Newswire HOUSTON, March 29, 2024 Expanded partnership to help increase patient access to critical genetic...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5.54 | -2.69967350519 | 205.21 | 208.32 | 198.06 | 705967 | 202.04575352 | CS |
4 | -11.62 | -5.49955038099 | 211.29 | 218.67 | 198.06 | 660657 | 209.07342314 | CS |
12 | -28.91 | -12.6476507131 | 228.58 | 229.54 | 198.06 | 751840 | 215.22479965 | CS |
26 | -2.32 | -1.14857171147 | 201.99 | 234.09 | 195.01 | 764381 | 214.96531049 | CS |
52 | -29.77 | -12.975069735 | 229.44 | 243.3 | 195.01 | 741570 | 214.79299002 | CS |
156 | -61.58 | -23.571291866 | 261.25 | 317.17 | 195.01 | 724281 | 243.76075221 | CS |
260 | 54.45 | 37.4948354221 | 145.22 | 317.17 | 98.02 | 739663 | 217.54705264 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions